11.12.2012 Views

continued from part 1 - Controller General of Patents, Designs, and ...

continued from part 1 - Controller General of Patents, Designs, and ...

continued from part 1 - Controller General of Patents, Designs, and ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

(12) PATENT APPLICATION PUBLICATION (21) Application No.6789/DELNP/2008 A<br />

(19) INDIA<br />

(22) Date <strong>of</strong> filing <strong>of</strong> Application :06/08/2008 (43) Publication Date : 24/10/2008<br />

(54) Title <strong>of</strong> the invention : "HEPATITIS C VIRUS NON STRUCTURAL FUSION PROTEIN"<br />

(51) International classification :A61K 39/29 (71)Name <strong>of</strong> Applicant :<br />

(31) Priority Document No :06360006.8<br />

1)TRANSGENE S.A.<br />

(32) Priority Date :09/03/2006<br />

Address <strong>of</strong> Applicant :11, RUE DE MOLSHEIM, F-67082<br />

(33) Name <strong>of</strong> priority country<br />

:EUROPEAN<br />

UNION<br />

STRASBOURG CEDEX FRANCE. France<br />

(72)Name <strong>of</strong> Inventor :<br />

(86) International Application No :PCT/EP2007/001922 1)FOURNILLEIR ANNE<br />

Filing Date<br />

:06/03/2007<br />

2)INCHAUSPE GENEVIEVE<br />

(87) International Publication No :WO 2007/101657 3)CHATER LAURENCE<br />

(61) Patent <strong>of</strong> Addition to Application<br />

Number<br />

Filing Date<br />

:NA<br />

:NA<br />

4)PENIN FRANCOIS<br />

(62) Divisional to Application Number :NA<br />

Filing Date<br />

:NA<br />

(57) Abstract :<br />

The present invention relates to an isolated fusion protein comprising at least three NS polypeptides originating <strong>from</strong> a hepatitis C<br />

virus which are configured in said fusion protein in an order which is distinct <strong>of</strong> the order in which they appear in the native<br />

configuration. The present invention also relates to a nucleic acid molecule encoding such a fusion protein <strong>and</strong> a vector comprising<br />

such a nucleic acid molecule. The present invention also provides infectious viral <strong>part</strong>icles <strong>and</strong> host cells comprising such a nucleic<br />

acid molecule or such a vector. The present invention also relates to a method for recombinantly producing such a fusion protein.<br />

Finally, the present invention also provides a pharmaceutical composition comprising such a fusion protein, a nucleic acid molecule, a<br />

vector, infectious viral <strong>part</strong>icles <strong>and</strong> a host cell as well as the therapeutic use there<strong>of</strong> for treating or preventing HCV infections, HCVassociated<br />

diseases <strong>and</strong> pathologic conditions as well as a method <strong>of</strong> inducing or stimulating an immune response against HCV in a<br />

host organism.<br />

No. <strong>of</strong> Pages : 108 No. <strong>of</strong> Claims : 36<br />

The Patent Office Journal 24/10/2008 26214

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!